Feldesman

Late last week, the U.S. Department of Health and Human Services (HHS) posted without any fanfare the promised revision to the HHS Grants Policy Statement (GPS), effective October 1, 2025.  This updated [...]

On September 4, 2025, Feldesman Managing Partner Ted Waters will deliver three presentations at the OKPCA Annual Conference in Oklahoma City, focusing on recent and anticipated federal funding changes for federally qualified [...]

The question of whether the qui tam provisions of the False Claims Act are constitutional—and whether whistleblowers may continue to litigate on behalf of the U.S. government—is now pending on appeal before [...]

Grantees Must File Separate Cases in U.S. District Court and the Court of Federal Claims The new Administration has rolled out executive orders directing federal agencies to review and terminate grants deemed [...]

On August 12, 2025, the court in State of New York, et al., v. USDOJ, et al., 25-cv-00345 (D. R.I.), entered an updated “Stipulation and Joint Proposal for Briefing Schedule” stating that [...]

“Improving Oversight of Federal Grantmaking” Gives Agency Heads More Control Over Federal Grant Review and Provides for Uniform Guidance Revisions A new Executive Order (EO) issued Thursday, August 7 continues—and expands upon—the [...]

On August 11, 2025, Feldesman Partners Mindy B. Pava and Ted Waters will present on the rapidly changing federal grants and enforcement landscape at the National Council of University Research Administrators’ (NCURA) [...]

On August 1, 2025, the Office of Pharmacy Affairs (OPA) of the Health Resources and Services Administration (HRSA) announced a pilot rebate program for purchases under the 340B drug discount statute of [...]

In recent months, the Administration has been adding a new condition to Federal awards that ties assurances that grantees comply with long-standing Federal antidiscrimination laws to a requirement that grantees refrain from [...]

DOJ Provides Guidance to Federal Funding Recipients on Unlawful Discrimination In an effort to eliminate the ambiguity over what constitutes “illegal DEI” or “unlawful discrimination,” the U.S. Department of Justice (DOJ) issued [...]